CD274 and neoplasm: For instance, HBV etiology itself may influence HLA-DR expression independently of immunotherapy response, and co-factors like PD-L1 levels, tumor stage, cirrhosis presence, or treatment regimens (e.g., monotherapy vs. combination) could affect outcomes.